Evidence map›Paper›PMID 30504234›Full record

ArticleBlood advances2018

Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish.

Megan S Rost, Ilya Shestopalov, Yang Liu, Andy H Vo, Catherine E Richter, Sylvia M Emly, Francesca G Barrett, David L Stachura, Michael Holinstat, Leonard I Zon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish.Research and practice in thrombosis and haemostasis · 2022
    Review
  9. Article
  10. Review
  11. TMEA, a Polyphenol inFrontiers in cell and developmental biology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Megan S RostDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.
Ilya ShestopalovBoston Children's Hospital and Harvard Medical School, Boston, MA.
Yang LiuDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.
Andy H VoDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.
Catherine E RichterDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.
Sylvia M EmlyDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-1429-3700
Francesca G BarrettBoston Children's Hospital and Harvard Medical School, Boston, MA.
David L StachuraDepartment of Biological Sciences, California State University Chico, Chico, CA.
Michael HolinstatDepartment of Pharmacology, University of Michigan, Ann Arbor, MI; and.ORCID 0000-0001-5100-1933
Leonard I ZonBoston Children's Hospital and Harvard Medical School, Boston, MA.ORCID 0000-0003-0860-926X
Jordan A ShavitDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-2874-4904
University of Michigan · USBoston Children's Hospital · USCalifornia State University, Chico · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2013 to 2026
$25.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Training Program in Molecular HematologyT32HL007622 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI, Jordan A. Shavit · 1986 to 2026
$9.2M
Stem cells for therapeutics discovery in genetic blood disordersU01HL134812 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q, LIPTON, JEFFREY M · 2016 to 2022
$8.3M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
Project-002U54DK110805 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ORKIN, STUART H, ZON, LEONARD IRA · 2016 to 2020
$5.9M
COMPARATIVE APPROACH TO GLOBIN REGULATION/THALASSEMIAR01DK053298 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1998 to 2012
$3.9M
Transcriptional response to signaling during hematopoiesisR01HL144780 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI ZON, LEONARD IRA · 2019 to 2022
$2.1M
Dissecting the Genetics of Human Hemostatic Disorders Using ZebrafishR01HL124232 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAVIT, JORDAN A · 2015 to 2019
$1.9M
Identification of novel therapeutics for hemostatic disorders using zebrafishR01HL125774 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAVIT, JORDAN A · 2018 to 2020
$899k
Howard Hughes Medical InstituteNCI NIH HHS P01 CA163222NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL124232NHLBI NIH HHS R01 HL125774NHLBI NIH HHS R01 HL144780NHLBI NIH HHS T32 HL007622NHLBI NIH HHS U01 HL134812NIDDK NIH HHS R01 DK053298NIDDK NIH HHS R15 DK114732NIDDK NIH HHS R24 DK092760NIDDK NIH HHS U54 DK110805NIGMS NIH HHS T32 GM007315NIH HHS R24 OD017870
6 · The paper itself

Abstract

The NFE2 transcription factor is expressed in multiple hematopoietic lineages with a well-defined role in regulating megakaryocyte biogenesis and platelet production in mammals. Mice deficient in NFE2 develop severe thrombocytopenia with lethality resulting from neonatal hemorrhage. Recent data in mammals reveal potential differences in embryonic and adult thrombopoiesis. Multiple studies in zebrafish have revealed mechanistic insights into hematopoiesis, although thrombopoiesis has been less studied. Rather than platelets, zebrafish possess thrombocytes, which are nucleated cells with similar functional properties. Using transcription activator-like effector nucleases to generate mutations in

Indexed as

Amino Acid SequenceAnimalsBlood PlateletsCodon, TerminatorFibrinogenFrameshift MutationGene EditingHumansLarvaNF-E2 Transcription FactorSequence AlignmentThrombopoiesisZebrafishZebrafish ProteinsCodon, TerminatorFibrinogenNF-E2 Transcription FactorZebrafish Proteins

Identifiers

PMID30504234
PMCPMC6290098
OpenAlexW2903193498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.